Karachi: GlaxoSmithKline Pakistan Limited has announced a strategic change in its Board of Directors following the resignation of Mr. Simon Foster. To address the vacancy, the Board has appointed Ms. Ana Paula De Freitas Passes as a Non-Executive Director, effective from February 07, 2025. Ms. Passes, who currently serves as Vice President of Local to Local Operations, Primary and Small Molecules Manufacturing at GlaxoSmithKline, brings a wealth of experience and expertise to the Board.

The resignation of Mr. Foster necessitated prompt action to ensure the continued effectiveness and leadership within the Board. By appointing Ms. Passes, the company aims to leverage her extensive background in operations and manufacturing to drive strategic initiatives and enhance corporate governance.

According to information available from the Pakistan Stock Exchange (PSX), GlaxoSmithKline Pakistan Limited operates within the pharmaceuticals and healthcare sector. This appointment is in line with the company's commitment to maintaining high standards of corporate governance and operational excellence.

The decision to bring Ms. Passes onto the Board underscores GlaxoSmithKline Pakistan Limited's focus on strengthening its leadership team to navigate the evolving dynamics of the pharmaceutical industry. Her appointment is expected to provide valuable insights that will contribute to the company's growth and success in the local market.